NCT06214819View on ClinicalTrials.gov

Plan to Evaluate Early Endothelialization of a Polymer Free Sirolimus-eluting Coronary Stent System (VIVO ISARTM) Compared With Everolimus-eluting Durable Polymer Stent (XIENCE SkypointTM) in Patients Undergoing Percutaneous Coronary Intervention.

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 20, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

January 31, 2026

Conditions
Coronary Artery Disease
Interventions
DEVICE

VIVO ISAR DES implanted in the First lesion, XIENCE Skypoint DES implanted in the Second lesion

VIVO ISAR DES implanted in the First lesion, XIENCE Skypoint DES implanted in the Second lesion

DEVICE

XIENCE Skypoint DES implanted in the First lesion, VIVO ISAR DES implanted in the Second lesion

XIENCE Skypoint DES implanted in the First lesion, VIVO ISAR DES implanted in the Second lesion

Trial Locations (4)

17007

RECRUITING

Hospital Universitario de Gerona Doctor Josep Trueta, Girona

08035

RECRUITING

Hospital Universitari Vall D'Hebron, Barcelona

08036

RECRUITING

Hospital Clinic Barcelona, Barcelona

08907

RECRUITING

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

All Listed Sponsors
lead

Fundación EPIC

OTHER